Background {#Sec1}
==========

Global malaria control and elimination programme advocates test and treat as one of the key strategies toward its achievements \[[@CR1], [@CR2]\]. In Tanzania, microscopy is still considered as a reference standard in malaria diagnosis at the point of care \[[@CR3]\]. However, routine use of microscopy for accurate diagnosis of malaria in the health facilities faces a number of challenges. These challenges include qualified human resources, stable electrical power supply, quality of blood slides, low parasite densities, and altered parasite morphology caused by chemoprophylaxis or empiric therapy \[[@CR3]--[@CR6]\].

Microscopic examination involves the quantification of malaria parasites against white blood cells (WBCs) or red blood cells (RBCs) \[[@CR7], [@CR8]\]. To quantify malaria parasites against RBCs, the parasitized RBCs among 500--2000 RBCs are quantified on the thin smear and results expressed as percentage parasitaemia. On the other hand, quantification of malaria parasites against WBCs are tailed against WBCs until 500 parasites or 1000 WBCs are counted, then express as parasites per microlitre of blood \[[@CR6]--[@CR8]\]. Rapid diagnostic test **(**RDT) is mostly used in countries with limited resources for diagnosis of malaria due its advantages in these settings. The advantages of RDT include easy to use, provision of results from whole blood within 20 min, easy to carry diagnostic kits and require less skilled personnel \[[@CR9], [@CR10]\].

Diagnosis using RDT are made to target different antigens, such as histidine-rich protein-2 (PfHPR2) for *Plasmodium falciparum*, *Plasmodium* lactate dehydrogenase (pLDH) and aldolase, which are common to all human *Plasmodium* species \[[@CR11]\]. Nevertheless, studies have reported variations in the accuracy for diagnosis of malaria when using RDT. For instance, diagnosis of malaria using RDT with PfHRP2 was reported to have slightly better sensitivity than *P. falciparum* lactate dehydrogenase (Pf-pLDH) detecting RDT \[[@CR11]--[@CR13]\].

Moreover, PfHRP2 tests have several other limitations, including persistence of the PfHRP2 antigens and false-positive reactions due to other infectious agents or immunological factors \[[@CR12]\]. In addition, findings from studies conducted in Rwanda \[[@CR14]\] and Senegal \[[@CR15]\] reported undetected cases with deletion of PfHRP2. However, blood smear microscopy (BS microscopy) remains to be the reference standard method for malaria diagnosis and monitoring of the treatment progression especially in malaria endemic regions \[[@CR3], [@CR6]--[@CR8], [@CR16]\]. Therefore, the current study aimed to evaluate the diagnostic performance of CareStart™ malaria HRP2/pLDH (Pf/pan) combo and its agreement to BS microscopy for diagnosis of malaria among clinically suspected malaria patients following the recent wide scale use of RDT for diagnosis of malaria in primary health centres in Tanzania.

Methods {#Sec2}
=======

Study area {#Sec3}
----------

This study was carried out at Kibiti Health Centre (KHC) situated in Kibiti District, Pwani region, Eastern Coast, Tanzania. Kibiti is one of the 8 districts of the Pwani Region of Tanzania. It is bordered to the North by the Kisarawe and Mkuranga Districts, to the East by the Indian Ocean, to the South by the Lindi Region and to the West by the Morogoro Region. The region has malaria cases through out the year with the approximated prevalence of 5.3%, where *P. falciparum* is responsible to more than 95% of all malaria cases \[[@CR17]\]. Currently, KHC as a district hospital attends both in-patient and outpatients where patients suspected with malaria are subjected to RDT testing then if found positive malaria management is initiated \[[@CR18]\].

Study design {#Sec4}
------------

This was a cross sectional study conducted between March and August 2019 with the aim of determining the diagnostic performance of RDT test compared to the blood smear (BS) microscopy as a standard method among patients of all ages with suspected malaria infection. Diagnostic accuracy, sensitivity, specificity, likelihood ratio (LR), and predictive values were calculated as described by Šimundić et al. \[[@CR19]\].

Study population {#Sec5}
----------------

Patients with age above 6 months attending clinic at KHC who presented with symptoms suggestive of malaria infection were recruited in the study. The symptoms such as fever, general body weakness and headache were confirmed by the attending physician \[[@CR20]\]. In addition, the attending physician interviewed patients on the regular use of insecticide-treated bed nets using Yes/No question. After physical examination, patients were directed to provide blood samples for diagnosis of malaria. Patients with severe malaria and children with malnutrition were excluded from the study.

Sample size and sampling technique {#Sec6}
----------------------------------

Nine hundred and eighty (980) participants were recruited to participate in this study. The sample size was calculated using single population proportion formula considering 95% confidence interval (CI) and proportion (P) of 5.7% \[[@CR17]\] as follows; *n* = Z~α/2~P (1 − P)/ε^2^ where n is sample size, Z~α/2~P = 1.96 for 95% confidence level, ε is the marginal error. All the recruited study participants were patients presenting with symptoms suggestive of malaria infection as determined by their attending clinicians. All malaria suspected patients between March and August 2019 were eligible to participate in the study.

Clinical assessment and laboratory procedures {#Sec7}
---------------------------------------------

### Determination of body temperature {#Sec8}

The armpit body temperature was measured using clinical digital thermometer as per manufacturer's specifications (IndiaMART, India). The body temperature of \< 37.5 °C and ≥ 37.5 °C were classified as normal and febrile fever, respectively \[[@CR21]\].

### Determination of haemoglobin levels {#Sec9}

Haemoglobin (Hb) level was measured photometrically by Hemocue Hb 201^+^ (Angelholm, Sweden) using microcuvette following manufacturer's instructions. The drop of blood was collected in Hb 201 microcuvette and read using HemoCue Hb 201 + device and results were recorded in g/dl. The Hb level of \< 6 g/dl, 6--11.5 g/dl and \> 11.5 g/dl were classified as anaemia, mild and normal, respectively, as previously described \[[@CR22]\].

Diagnosis of malaria by CareStart™ malaria HRP2/pLDH (Pf/pan) Combo test {#Sec10}
------------------------------------------------------------------------

Diagnosis of malaria by rapid test was done according to manufacturer's instructions using CareStart™ malaria (Lot 05EDE011A, Access Bio, Ethiopia) stored at temperature between 2 °C and 30 °C. Briefly, two laboratory technicians recorded the results independently during the daylight, assisted by a standard electric bulb. The laboratory technicians were blinded to each other's readings and to the results of microscopy. The discrepancies were resolved using a third reader.

### Diagnosis of malaria by microscopy {#Sec11}

Duplicate thin and thick blood films were prepared. A total of 980 patients, i.e. both CareStart™ malaria positive and negative individuals were subjected to BS microscopy. Slides containing thin and thick smears were air-dried for 30 min at room temperature followed by staining with 5% Giemsa (GIBCO, Scotland, UK) at pH 7.2. After staining, the slides were examined by two independent experienced microscopists (undergone national or regional training and certified to perform malaria testing by Tanzania Ministry of Health) using light microscopy with 1000 × oil- immersion lenses. Briefly, malaria parasites count was recorded until 200 leukocytes were counted. If less than 10 parasites were found, counting was extended to 500 leukocytes \[[@CR23]\]. Parasite densities were calculated by assuming a total leukocyte count of 8000/μl (17). For quality control, 100 blood slides were randomly selected and observed by a senior microscopist at Muhimbili University of Health and Allied Sciences. In addition, a senior microscopist was also used to resolve discrepancies between the readers.

Data management and analysis {#Sec12}
----------------------------

Information recorded in the data collection sheet were entered in Microsoft Excel sheet (Redmond, WA) and exported to Prism 7 software (GraphPad Software, USA) for determining the CareStart™ malaria diagnostic accuracy. Sensitivity, specificity, LR and predictive values were obtained using two-by-two cross table. Agreement between CareStart™ and BS microscopy was determined by Cohen's kappa test using statistical package for social sciences (SPSS version 25 software, Chicago Inc., USA). The value of kappa, \< 0.59, 0.6--0.79, 0.8--0.9 and \> 0.9 were considered weak, moderate, strong and almost perfect agreement, respectively \[[@CR24]\]. Likelihood ratios for positive (LR+) and negative (LR)-test results were considered good when LR+ was \> 10, and LR− \< 0.1. The diagnostic accuracy was explored from receiver-operating characteristics (ROC) curve. Using the area under the curve (AUC) for determination of diagnostic accuracy; 0.9--1.0, 0.8--0.9, 0.7--0.8, 0.6--0.7, 0.5--0.6, and \< 0.5 were considered equivalent to excellent, very good, good, sufficient, bad and test not useful, respectively \[[@CR18], [@CR22]\]. The *P* value for significance was considered at \< 0.05.

Ethical consideration {#Sec13}
---------------------

Ethical approval (Reference number DA.282/298/01A.C/) was obtained from Muhimbili University of Health and Allied Sciences Institutional Review Board. In addition, the National Institute for Medical Research also provided ethical clearance (Reference number NIMR/HQ/R.8A/Vol.IX/3107) for this study. Written informed consent was obtained from each study participant and from parent/legal guardian for children. Furthermore, verbal assent was obtained from children with age above 5 years before requesting consent from their parents/legal guardian. Permission to conduct the study at KHC was obtained from both Kibiti District Medical Officer and KHC Medical officer in-charge. Consented patients were requested to give blood spots from a finger prick for RDT, thick and thin blood smears for microscopy. Patients found positive for malaria by microscopy and those with low Hb levels were immediately communicated to their attending physician for further management. Names and other personal details were not disclosed for confidentiality purposes.

Results {#Sec14}
=======

Participants' recruitment flow chart {#Sec15}
------------------------------------

A total of 980 were clinically suspected to have malaria infection. Of 980 patients, 567 (57.9%) were found to be malaria positive as determined by CareStart™, while 413 patients were malaria negative. Both CareStart™ malaria positive and negative individuals were subjected to BS microscopy. Out of the 413 patients who were malaria negative by CareStart™, one patient (0.2%) was confirmed positive by BS microscopy. Therefore, out of 980 individuals who were suspected to have malaria infection based on presenting symptoms, only 510 patients (52%) were confirmed by microscopy to be malaria positive (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Study participants' malaria diagnosis flow chart (n = number of cases)

General characteristics of patients {#Sec16}
-----------------------------------

Out of the 980 participants who were recruited to participate in the study, 529 (54%) were females. The median \[Interquartile Range (IQR)\] age was 6 (3--18.5) years whereas 394 (40.1%) participants had age below 5 years. A total of 894 participants (91.3%) reported the use of insecticide-treated bed nets. The mean \[(Standard deviation (± SD)\] haemoglobin level was 10.5 (1.7) g/dl and 776 (79.2%) participants had mild anaemia. A majority (65.6%) of the participants had fever. Of the 510 BS positive patients, 487 (95.5%) were *P. falciparum* mono-infected. The rest 13 (4.6%) patients were infected with other species of *Plasmodium*. The geometric mean parasite density was 2921 parasites/μl, whereas the majority (68.6%) of patients had parasite density of above 10,000/µl (Table [1](#Tab1){ref-type="table"}).Table 1Participants' and malaria parasites characteristics (n = number of cases)Characteristicsn (%)Gender Male451 (46) Female529 (54)Median age (years) Median (IQR)6 (3--18.5)Age group (years) \< 5394 (40.1) 5--18343 (35) \> 18244 (24.9)Pregnant women74 (7.5)Use of insecticide-treated bed nets Yes894 (91.3) No86 (8.7)Mean Hb level (g/dl) Mean ± SD10.5 ± 1.7Hb level distribution (g/dl) \< 613 (1.3) 6--11.5776 (79.2) \> 11.5191 (19.5)Mean body temperature (°C) Mean ± SD37.8 ± 1.4Category of body temperature (°C) \< 37.5337 (34.4) ≥ 37.5643 (65.6)Plasmodium species Pf487 (95.5) Non-Pf (pan)13 (4.6)Geometric mean parasite density per μl2921Parasite density distribution (parasites/μl) \< 100040 (7.8) 1000--10,000120 (23.6) \> 10,000350 (68.6)

CareStart™ malaria HRP2/pLDH (Pf/pan) Combo test diagnostic performance {#Sec17}
-----------------------------------------------------------------------

The sensitivity and specificity of CareStart™ were 99.8% \[(95% CI 98.9%--99.9%) and 87.6% (95% CI 84.4%--90.3%). The positive predictive value was 89.8% (95% CI 87%--92%) while the negative predictive value was 99.8% (95% CI 98.6%--99.9%). The LR+ and LR− were 8.0 and 0.002, respectively (good diagnostic tests have LR+ \> 10 and LR− \< 0.1). The diagnostic accuracy for malaria was 0.5 (95% CI − 0.193 to 1.193). There was a strong agreement for the accuracy malaria diagnosis between CareStart™ and BS Microscopy (kappa = 0.863, P \< 0001) (Table [2](#Tab2){ref-type="table"}).Table 2Diagnostic performance of CareStart™ using BS microscopy as a standard methodTestBS microscopyPositive (n)Negative (n)CareStart™ Positive50958 Negative1412Measures of diagnostic performanceValueSensitivity (95% CI) (%)99.8 (98.9 to 99.9)Specificity (95% CI) (%)87.6 (84.4 to 90.3)Positive predictive value (95% CI) (%)89.8 (87 to 92)Negative predictive value 95% CI) (%)99.8 (98.6 to 99.9)Diagnostic accuracy (95% CI)0.5 (− 0.193 to 1.193)Likelihood ratio of a positive test8.0Likelihood ratio of a negative test0.002Cohen's kappa, p value0.863, \< 0001

Discussion {#Sec18}
==========

The WHO recommends parasitological-based tests microscopy and RDT for detection of plasmodium infections at the points of care \[[@CR8]\]. Since 2009, the Ministry of Health in Tanzania has been scaling up the use of RDT in the public health facilities \[[@CR21]\]. However, there are several conflicting reports on diagnostic performance of RDT at the point of care leading to over or under prescribing of anti-malarial drugs \[[@CR10], [@CR15], [@CR26]\].

In this study, the diagnostic performance of CareStart™ malaria HRPII/pLDH Combo test in Kibiti health centre, which has moderate malaria transmission, was evaluated. The findings show that malaria infections among the suspected patients were 57.9% and 52% as detected by RDT and microscopy respectively. The overall sensitivity and specificity of the CareStart™ was found to be 99.8% and 87.6%, respectively. These results indicate that, CareStart™ had high sensitivity with slightly lower specificity (\< 90%) compared to microscopy.

CareStart™ combo performance has been evaluated using microscopy as the reference standard in different malaria transmission settings \[[@CR26], [@CR27]\]. High sensitivity results reported in this study are related to high parasite density (\> 1000 parasites/ul) for the majority of patients tested. Previous studies have reported increase in sensitivity when parasite density was \> 100 parasites/ul \[[@CR27]\]. In addition, the findings of this study are in line with the study conducted in Ethiopia (26) which also reported good accuracy and strong agreement between RDT and light microscopy among malaria suspected patients.

In this study, the sensitivity and specificity for detection of malaria by RDT was 99.8% and 87.9% respectively. This is slightly different the overall sensitivity and specificity of 95% and 94.2%, respectively that was reported from Ethiopian patients \[[@CR26]\] respectively Other studies have also reported high sensitivity of CareStart™ combo for detection of *P. falciparum* \[[@CR14], [@CR21], [@CR27]\]. Factors such as mutation in parasite histidine-rich protein-2 reduce has been reported to be the cause the variations in diagnostic accuracy, especially sensitivity of the RDT \[[@CR14], [@CR15]\]. However, the results of the current study have reported higher sensitivity than the specificity.

For RDT to have good specificity during diagnosis of malaria, screening procedure, which is clinical examination, should be robust. This study used clinical malaria symptoms such as fever, general body weakness and headache as recommended in the national malaria treatment guidelines to guide diagnosis \[[@CR16]\]. However, most of signs and symptoms for uncomplicated malaria resemble those of urinary tract infections, respiratory tract infections and gastrointestinal infections, which are common in Tanzania \[[@CR3]\]. In this study, out of 980 individuals who were suspected to have malaria infection based on presenting symptoms, only 510 patients (52%) were confirmed to be malaria positive by microscopy. These findings support recommendations by the Tanzania Malaria Treatment Guidelines \[[@CR20]\] emphasizing that diagnosis of malaria should be based on laboratory results using RDT and microscopy where available.

Over diagnosis of febrile infections which lead to irrational use of anti-malarial drugs has been reported in Tanzania \[[@CR3]\], and this could be the reason for the observed low specificity compared to what has been reported elsewhere \[[@CR27]\]. RDT accuracy is affected with the recent use of antimalarial drugs and therefore patient history of drug use is important for interpretation of RDT results \[[@CR3]\]. In a study that was conducted in China-Myanmar malaria endemic borders, the sensitivity and specificity of CareStart™ RDT were 88.5% and 98.26%, respectively.

Another probable cause for discrepancies in diagnostic accuracy of RDT for malaria is the differences in the prevalence of *Plasmodium* species \[[@CR14], [@CR15], [@CR27]\]. For instance, a study conducted in China-Myanmar malaria endemic borders reported high sensitivity of *Plasmodium vivax* (98.26%) compared to *P. falciparum* (88.52%) when using CareStart™ kit' \[[@CR27]\]. In the latter study, the specificity for diagnosis of *Plasmodium* species using CareStart™ kit' was also higher for *P. vivax* (100%) compared to *P. falciparum* (90.77%). In this study, the most prevalent *Plasmodium* species was *P. falciparum* (95.5%) and, therefore, a comparison of diagnostic performance of CareStart™ RDT in individuals infected with different species of *Plasmodium* could not be made.

The diagnostic accuracy in terms of specificity (87%) results observed in this study (when using CareStart™ combo test are similar to the specificity of 84% which was reported in the study conducted in Rwanda when HRP2 + pLDH RDT was used (14). These results are an indication that RDT perform better when all of *Plasmodium* species are considered. In this study, the geometric mean parasite density was 2921 parasites/µl whereas majority of patients had parasite density greater than 10,000/µl. Although the current study did not further perform statistical analysis to establish an association between parasite density and RDT sensitivity to malaria parasites, however findings from the study which was conducted in Madagascar reported low sensitivity (60.0%) of *P. falciparum* at densities of \< 100/μl and increasing sensitivity (100%) at higher parasite densities of \> 500/μl \[[@CR25]\].

In this study we compared the diagnostic performance of CareStart™ malaria HRP2/pLDH (Pf/pan) combo test in comparison with standard microscopy for detection of malaria infection among symptomatic patients. Although the results of this study have shown good performance of RDT for detection of falciparum malaria in line with the national malaria treatment guidelines \[[@CR20]\], the use of nucleic acid-based test like PCR would have provided more evidence for comparison purposes \[[@CR26], [@CR27]\]. Notwithstanding this limitation, the results of this study supports continued use of RDT in areas with limited qualified human resources, electrical power supply and supportive infrastructure. Lastly this study did collect the information regarding the recent use of anti-malarials.

Conclusion {#Sec19}
==========

CareStart™ malaria HRP2/pLDH (Pf/pan) had high sensitivity and strong agreement with microscopy results. However, moderate specificity of RDT resulted in substantial number of patients with false positive malaria test. It is recommended that in areas with moderate to high malaria transmission, BS microscopy should be performed to confirm RDT positive results.
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